Instant clinical trial intelligence—without the enterprise price tag.
Clinical trial intelligence has never been more important. Yet for many professionals, meaningful insights remain difficult to access, not only because of cost, but because of complexity.
For years, clinical intelligence has sat behind two walls:
- A paywall, driven by enterprise licensing and budget constraints
- A knowledge wall, created by complex systems, advanced tool knowledge, and steep learning curves
At TA Scan , we believe clinical intelligence should be powerful and approachable. That belief led to OpenTA by TA Scan – a new, self-service way to explore the clinical landscape using trusted data, without requiring enterprise budgets or specialized expertise.
The Problem: Clinical Intelligence Has Been Locked Behind Walls
Clinical development teams are expected to move faster and make smarter decisions earlier than ever before. Yet access to usable clinical intelligence remains uneven across the ecosystem.
Many professionals still rely on:
- Public registries like ClinicalTrials.gov as a primary “strategy tool”
- Manual analysis and fragmented datasets
- Tools that require advanced analytical skills to extract basic insights
At the same time, entire groups are underserved by traditional enterprise platforms:
- Clinicians and academic researchers exploring disease landscapes
- Consultants supporting early-stage strategy
- Students building real-world understanding of clinical development
- Small and emerging biotechs without enterprise budgets
This challenge extends beyond cost. Even when data is available, turning it into insight often requires navigating complex systems and advanced analytics, creating a knowledge barrier that slows exploration and limits adoption. The result? Slower insights, higher risk, and missed opportunities, especially in the early stages of planning and exploration. Clinical intelligence shouldn’t be locked behind cost or complexity.
TA Scan: Trusted, Operational, and Strategic Clinical Intelligence
TA Scan is a highly trusted clinical intelligence platform used by pharma, biotech, and CROs to support:
- Strategic feasibility and trial planning
- Site and investigator selection
- Competitive landscape analysis
- Diversity and patient-centric strategies
It is designed for operational and strategic decision-making, powered by deep data, advanced analytics, and configurable workflows.
But not every use case requires that full level of depth and not every user has access to an enterprise license.
That’s where OpenTA comes in.
Introducing OpenTA: Lowering the Barriers to Insight
OpenTA by TA Scan is a self-serve, exploratory clinical intelligence solution designed to lower both the paywall and the knowledge wall.
Built on the same high-quality data trusted by pharma and life sciences organizations, OpenTA enables users to:
- Quickly explore high-level insights into clinical trials, sites, and investigators
- Use simple filters and intuitive dashboards to find relevant insights
- Gain a clear, immediate view of trial activity and trends within specific therapeutic areas
OpenTA is intentionally focused on clarity, speed, and accessibility. It delivers a first look at the clinical landscape, without requiring advanced analytics, complex configuration, or deep platform expertise.
For teams and organizations ready to move beyond exploration, TA Scan extends these insights with deeper data access, advanced analytics, and operational workflows that support strategic planning, feasibility, and trial delivery.
Together, OpenTA and TA Scan form a single clinical intelligence ecosystem, supporting everything from first-look exploration to enterprise-scale decision-making.
Why OpenTA and Why Now?
The clinical development ecosystem is evolving:
- Decisions are happening earlier
- Teams are leaner
- Budgets are under pressure
- Speed matters more than ever
By opening up access to trusted clinical intelligence, TA Scan is redefining what “at your fingertips” really means.
Data trusted by pharma, now available to individuals.
OpenTA and TA Scan: One Ecosystem, Designed for Different Depths
OpenTA is not a replacement for TA Scan. It’s an extension of the TA Scan vision.
TA Scan remains a highly trusted, enterprise-grade clinical intelligence platform supporting:
- Strategic feasibility and trial planning
- Site and investigator selection
- Competitive landscape analysis and diversity strategies
OpenTA lowers the barrier to entry. TA Scan delivers the full power of clinical intelligence.
Together, they form a scalable clinical intelligence ecosystem, supporting everything from early exploration to enterprise decision-making.
Your Shortcut to Understanding the Clinical Landscape
Still using ClinicalTrials.gov as your strategy tool? There’s a better way.
With OpenTA by TA Scan, clinical intelligence becomes more accessible, more intuitive, and easier to act on, without sacrificing trust or quality.
Explore the landscape. Validate your thinking. And when you’re ready to go deeper, TA Scan is there.
OpenTA by TA Scan.
TA Scan by Anju Software.
Images used under license by https://stock.adobe.com/
Authored by Elke Ydens, Associate Director of Business Solutions, Data Division
Elke Ydens, Associate Director of Business Solutions at Anju’s Data Division, brings over a decade of life sciences experience and a PhD in Biochemistry and Biotechnology from the University of Antwerp. As a Subject Matter Expert in Data Science, she adeptly addresses customer needs, leveraging her background in neuro-immunology and biochemistry. Elke remains dedicated to professional growth, contributing to industry publications, and staying updated on industry trends, while also finding success in extracurricular pursuits, formerly competing in world and European bridge championships, and more recently active in beekeeping and coaching. Connect with Elke on LinkedIn to explore her achievements further.